[Pharmacologic and non-pharmacologic pain-therapy in neonatology: synopsis of the current data]

C Hünseler1, B Roth

  • 1Bereich Neonatologie, Kinderklinik des Klinikums der Universität zu Köln, Köln. christoph.huenseler@uni-koeln.de

Klinische Padiatrie
|February 2, 2008
PubMed

Insights

Neonatal pain management is crucial for preterm and term infants, despite its prevalence in neonatal intensive care. This review evaluates current pain relief strategies for common neonatal procedures.

Area of Science:

  • Neonatalogy
  • Pain Medicine
  • Pediatric Intensive Care

Context:

  • Early pain experiences negatively impact preterm and term neonates' acute and long-term outcomes.
  • Pain is frequently encountered in neonatal intensive care settings.
  • Existing pain therapies, both pharmacologic and nonpharmacologic, show variable efficacy.

Purpose:

  • To provide a comprehensive overview of current pain management strategies for neonates undergoing invasive procedures.
  • To evaluate the benefits and drawbacks of various pain alleviation methods for neonates.

Summary:

  • This article reviews pain management techniques for neonates during endotracheal suctioning, eye examinations, and mechanical ventilation.
  • It assesses the efficacy and safety of different pharmacologic and nonpharmacologic interventions.
  • The review aims to guide clinical practice in neonatal pain control.

Impact:

  • Improved understanding of neonatal pain management can lead to better patient outcomes.
  • Evidence-based strategies can optimize pain relief for vulnerable neonates.
  • This review supports the development of standardized pain protocols in neonatal intensive care.
Abstract

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...